GeoVax shareholders approve reverse stock split at special meeting

GeoVax Labs shareholders approved a reverse stock split ranging from 1-for-10 to 1-for-25, with the board to set the final ratio. They also authorized issuing up to 11,395,256 common shares upon exercise of warrants issued to an institutional investor.